Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-02 · accession 0001765581-22-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-04 | 2022-05-02 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale+OE | $156.63 | -7,260 | 350.2K | -2% | -$1.14M |
| D | 2022-05-04 | 2022-05-02 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $46.83 | +9,700 | 355.8K | +3% | +$454.3K |
| D | 2022-05-04 | 2022-05-02 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $0.00 | -9,700 | 29.0K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-05-02 | S | D | 716 | $158.53 | 349,502 | D | — | — | (F5) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $157.885 to $158.67. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2022-05-02 | S | D | 1,000 | $158.67 | 348,502 | D | — | — | |
| 3 | Common | Ordinary Shares | 2022-05-02 | M | A | 9,700 | $46.83 | 355,762 | D | — | — | |
| 4 | Common | Ordinary Shares | 2022-05-02 | S | D | 1,600 | $155.34 | 354,162 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $154.77 to $155.70. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 5 | Common | Ordinary Shares | 2022-05-02 | S | D | 3,177 | $156.13 | 350,985 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $155.79 to $156.57. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 6 | Common | Ordinary Shares | 2022-05-02 | S | D | 767 | $156.97 | 350,218 | D | — | — | (F4) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $156.84 to $157.11 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-05-02 | M | D | 9,700 | $0.00 | 29,032 | D | $46.83 · — to 2022-08-08 | 9,700 Ordinary Shares | (F7) This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016. |